SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-409460
Filing Date
2014-11-12
Accepted
2014-11-12 16:56:19
Documents
14
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d809245d10q.htm 10-Q 383158
2 EX-4.1 d809245dex41.htm EX-4.1 257972
3 EX-4.3 d809245dex43.htm EX-4.3 144620
4 EX-31.1 d809245dex311.htm EX-31.1 8725
5 EX-31.2 d809245dex312.htm EX-31.2 8699
6 EX-32.1 d809245dex321.htm EX-32.1 4367
7 EX-32.2 d809245dex322.htm EX-32.2 4315
14 GRAPHIC g809245g55v59.jpg GRAPHIC 136484
  Complete submission text file 0001193125-14-409460.txt   4077012

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT aeri-20140930.xml EX-101.INS 448896
9 XBRL TAXONOMY EXTENSION SCHEMA aeri-20140930.xsd EX-101.SCH 39565
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aeri-20140930_cal.xml EX-101.CAL 53665
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aeri-20140930_def.xml EX-101.DEF 97712
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeri-20140930_lab.xml EX-101.LAB 296467
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeri-20140930_pre.xml EX-101.PRE 203567
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 141214806
SIC: 2836 Biological Products, (No Diagnostic Substances)